tirzepatide insulin Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Tirzepatide | GLP-1R and GIPR

[4] Head-to-head clinical trials in type 2 diabetes tell the same story, with tirzepatide out front on weight and glycemic numbers both, and the systematic review pile only points one way

In a different way, Tirzepatide works by going after GLP-1 and glucose-dependent insulinotropic polypeptide receptors

The medical literature does not yet provide a reliable biomarker for predicting who can stop successfully

Two patients losing the same percentage of body weight may have very different risk profiles: Risk is behavioural, not automatic

Taken together, all these issues make less weight loss an expected finding in SELECT, compared with STEP 1

Neuron 85 , 257273 (2015)